Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEEFJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,284
Award facts
- Contract value 100% obligated
- $15,283.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a delivery order valued at $15,283.99 by the Defense Logistics Agency on January 28, 2026. This firm fixed-price delivery order, issued under no set-aside designation, represents pharmaceutical products and medical consumables to support Department of Defense healthcare operations. The award is structured as a delivery order under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion federal acquisition strategy designed to provide recurring medical supply support to military healthcare facilities worldwide.
Under the parent PPV-G GEN V contract awarded on November 13, 2025, with a $499.9 million ceiling and completion date of December 31, 2036, DMS Pharmaceutical Group is authorized to supply an extensive range of pharmaceuticals including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables across multiple therapeutic categories. The company's established performance on numerous prior delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system. This delivery order is scheduled for ultimate completion on January 29, 2026, and represents part of the Defense Logistics Agency's ongoing effort to maintain critical pharmaceutical supply chains supporting military personnel and healthcare operations globally.
Quick answers
Who was awarded contract SPE2DU26FEEFJ?
SPE2DU26FEEFJ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DU26FEEFJ worth?
The government has obligated $15,284 on SPE2DU26FEEFJ.
Is contract SPE2DU26FEEFJ an order under another contract?
Yes. SPE2DU26FEEFJ is a delivery order under SPE2DU25D9439, an indefinite delivery contract.
Was contract SPE2DU26FEEFJ competed?
The extent of competition for SPE2DU26FEEFJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award